Suchergebnisse - "Nowecki, Zbigniew"

PubPharm (101)

1

TROPION-Breast01 : Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer

enthalten in: Future oncology (London, England) | 2024

von Bardia, A. | Jhaveri, K. | Kalinsky, K. | +21

2

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer : Results From the Randomized, Phase II acelERA Breast Cancer Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Martín, M. | Lim, E. | Chavez-MacGregor, M. | +119

3

Ribociclib plus Endocrine Therapy in Early Breast Cancer

enthalten in: The New England journal of medicine | 2024

von Slamon, D. | Lipatov, O. | Nowecki, Z. | +28

4

Retrospective Observational Study to Determine the Epidemiology and Treatment Patterns of Patients with Triple-Negative Breast Cancer

enthalten in: Cancers | 2024

von Rosińska, M. | Dubiański, R. | Konieczna, A. | +4

5

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting : final analysis of LUCY

enthalten in: Breast cancer research and treatment | 2024

von Balmaña, J. | Fasching, P. | Couch, F. | +123

6

Expression of Soluble Form of Aurora A as a Predictive Factor for Neoadjuvant Therapy in Breast Cancer Patients : A Single-Center Pilot Study

enthalten in: Cancers | 2023

von Winter, P. | Fuksiewicz, M. | Jagiello-Gruszfeld, A. | +2

7

Immediate breast reconstruction in breast cancer patients with the use of Serasynth and SeragynBR synthetic meshes. Single-oncological center experience, analysis of complications

enthalten in: Polski przeglad chirurgiczny | 2023

von Grous, A. | Mazur, S. | Winter, P. | +4

8

Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD) : The protocol of ANTEC study

enthalten in: PloS one | 2023

von Borowiec, A. | Ozdowska, P. | Rosinska, M. | +15

9

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Geyer, C. | Garber, J. | Gelber, R. | +174

10

Trastuzumab Biosimilar ABP 980 Plus Pertuzumab and Docetaxel in the Therapy of Metastatic Breast Cancer: Real World Experiences from the National Research Institute of Oncology in Warsaw

enthalten in: Preprints.org | 2022

von Miacz, K. | Jagiełło-Gruszfeld, A. | Kunkiel, M. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]